Pluristem Therapeutics Inc (PSTI):企業の財務・戦略的SWOT分析

◆英語タイトル:Pluristem Therapeutics Inc (PSTI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14821
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pluristem Therapeutics Inc (Pluristem) is a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be administered to patients without tissue or genetic matching. The company’s product pipeline includes PLX-PAD for critical limb ischemia (CLI), intermittent claudication (IC), orthopaedic conditions, pulmonary arterial hypertension and women’s health; PLX-Immune for kidney, colorectal, breast, lung, muscle, skin and liver cancers; and PLX-R18 for hematological system and acute radiation syndrome (ARS). The company harnesses its proprietary 3D cell expansion platform technology for developing its cell therapies. It works in partnership with medical, pharmaceutical and academic institutions to develop its product portfolio. Pluristem is headquartered in Haifa, Israel.

Pluristem Therapeutics Inc Key Recent Developments

Feb 20,2019: Pluristem enters into collaboration with NASA to study PLX Therapeutic benefits in space missions
Jan 22,2019: Pluristem to collaborate with Israeli Ministry of Defense in the treatment of burn injuries
Jan 09,2019: Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger s Disease Patient
Dec 04,2018: Pluristem Therapeutics Enters into Cell Thawing Device License Agreement with Chart Industries, Inc.
Nov 29,2018: The Real Impact of PAD – Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease

This comprehensive SWOT profile of Pluristem Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Pluristem Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Pluristem Therapeutics Inc – Key Information
Pluristem Therapeutics Inc – Overview
Pluristem Therapeutics Inc – Key Employees
Pluristem Therapeutics Inc – Key Employee Biographies
Pluristem Therapeutics Inc – Key Operational Heads
Pluristem Therapeutics Inc – Major Products and Services
Pluristem Therapeutics Inc – History
Pluristem Therapeutics Inc – Company Statement
Pluristem Therapeutics Inc – Locations And Subsidiaries
Pluristem Therapeutics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Pluristem Therapeutics Inc – Business Description
Pluristem Therapeutics Inc – Corporate Strategy
Pluristem Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Pluristem Therapeutics Inc – Strengths
Pluristem Therapeutics Inc – Weaknesses
Pluristem Therapeutics Inc – Opportunities
Pluristem Therapeutics Inc – Threats
Pluristem Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Pluristem Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Pluristem Therapeutics Inc, Key Information
Pluristem Therapeutics Inc, Key Ratios
Pluristem Therapeutics Inc, Share Data
Pluristem Therapeutics Inc, Major Products and Services
Pluristem Therapeutics Inc, History
Pluristem Therapeutics Inc, Key Employees
Pluristem Therapeutics Inc, Key Employee Biographies
Pluristem Therapeutics Inc, Key Operational Heads
Pluristem Therapeutics Inc, Other Locations
Pluristem Therapeutics Inc, Subsidiaries
Pluristem Therapeutics Inc, Key Manufacturing facilities
Pluristem Therapeutics Inc, Key Competitors
Pluristem Therapeutics Inc, SWOT Analysis
Pluristem Therapeutics Inc, Ratios based on current share price
Pluristem Therapeutics Inc, Annual Ratios
Pluristem Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Pluristem Therapeutics Inc, Performance Chart
Pluristem Therapeutics Inc, Ratio Charts

★海外企業調査レポート[Pluristem Therapeutics Inc (PSTI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • All in West! Capital Corporation:戦略・SWOT・企業財務分析
    All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Wanhua Chemical Group Co Ltd (600309):企業の財務・戦略的SWOT分析
    Wanhua Chemical Group Co Ltd (600309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Imperial Oil Limited:企業の戦略・SWOT・財務分析
    Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report Summary Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • OTK GROUP, a.s.:企業の戦略・SWOT・財務分析
    OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report Summary OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • IHI Corporation:企業の戦略・SWOT・財務分析
    IHI Corporation - Strategy, SWOT and Corporate Finance Report Summary IHI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • PNM Resources, Inc. (PNM):電力:M&Aディール及び事業提携情報
    Summary PNM Resources, Inc. (PNMR) is an energy holding company. Through its utilities PNM and TNMP, the company generates, transmits, and distributes electricity; and transports natural gas. It produces electricity from coal, natural gas, nuclear, solar, wind, and geothermal sources. Through long-t …
  • PetroRio SA (PRIO3):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroRio SA (PetroRio), formerly HRT Participacoes em Petroleo SA, a subsidiary of HRT Oil & Gas Ltd, is oil and gas company that offers investment and recovering of oil production assets. The company offers development of solid growth platforms aiming to generate value to its shareholders b …
  • TTM Technologies, Inc.:企業の戦略・SWOT・財務情報
    TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fomento de Construcciones y Contratas SA (FCC):企業の財務・戦略的SWOT分析
    Fomento de Construcciones y Contratas SA (FCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary SATT Conectus Alsace SAS (Conectus Alsace), a subsidiary of SATT Association, is a technology transfer service provider. The company offers services such as single entry point, well-defined research collaborations, technology transfers, accessible technology platforms, license approach, inde …
  • Shiseido Company, Limited:戦略・SWOT・企業財務分析
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Calumet Specialty Products Partners LP (CLMT):石油・ガス:M&Aディール及び事業提携情報
    Summary Calumet Specialty Products Partners LP (Calumet) is a downstream energy company that produces specialty hydrocarbon and fuel products. It processes crude oil and other feedstock into a wide range of solvents, lubricating oils, white mineral oils, petrolatums and waxes; and into fuel and fuel …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cadence Design Systems Inc (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems Inc (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Baloise Belgium NV:企業の戦略・SWOT・財務分析
    Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report Summary Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vattenfall AB-エネルギー分野:企業M&A・提携分析
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • ICU Medical Inc (ICUI)-医療機器分野:企業M&A・提携分析
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆